<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="hwp">eLife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">33111</article-id><article-id pub-id-type="doi">10.7554/eLife.33111</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Biochemistry</subject></subj-group><subj-group subj-group-type="heading"><subject>Biophysics and Structural Biology</subject></subj-group></article-categories><title-group><article-title>Structural insights into the assembly and polyA signal recognition mechanism of the human CPSF complex</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-100316"><name><surname>Clerici</surname><given-names>Marcello</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-100317"><name><surname>Faini</surname><given-names>Marco</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="par-2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-1317"><name><surname>Aebersold</surname><given-names>Ruedi</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="other" rid="par-3"/><xref ref-type="other" rid="par-4"/><xref ref-type="other" rid="par-5"/><xref ref-type="other" rid="par-6"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-3463"><name><surname>Jinek</surname><given-names>Martin</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-7601-210X</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor2">*</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><institution content-type="dept">Department of Biochemistry</institution>, <institution>University of Zurich</institution>, <addr-line><named-content content-type="city">Zurich</named-content></addr-line>, <country>Switzerland</country></aff><aff id="aff2"><institution content-type="dept">Department of Biology, Institute of Molecular Systems Biology</institution>, <institution>Swiss Federal Institute of Technology</institution>, <addr-line><named-content content-type="city">Zurich</named-content></addr-line>, <country>Switzerland</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-1166"><name><surname>Proudfoot</surname><given-names>Nick J</given-names></name><role>Reviewing editor</role><aff><institution>University of Oxford</institution>, <country>United Kingdom</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><label>*</label>For correspondence: <email>aebersold@imsb.biol.ethz.ch</email> (RA);</corresp><corresp id="cor2"><label>*</label>For correspondence: <email>jinek@bioc.uzh.ch</email> (MJ);</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>23</day><month>12</month><year>2017</year></pub-date><volume>6</volume><elocation-id>e33111</elocation-id><history><date date-type="received"><day>26</day><month>10</month><year>2017</year></date><date date-type="accepted"><day>21</day><month>12</month><year>2017</year></date></history><permissions><copyright-statement>Â© 2017, Clerici et al</copyright-statement><copyright-year>2017</copyright-year><copyright-holder>Clerici et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-33111-v1.pdf"/><abstract><p>3' polyadenylation is a key step in eukaryotic mRNA biogenesis. In mammalian cells, this process is dependent on the recognition of the hexanucleotide AAUAAA motif in the pre-mRNA polyadenylation signal by the Cleavage and Polyadenylation Specificity Factor (CPSF) complex. A core CPSF complex comprising CPSF160, WDR33, CPSF30 and Fip1 is sufficient for AAUAAA motif recognition, yet the molecular interactions underpinning its assembly and mechanism of PAS recognition are not understood. Based on cross-linking-coupled mass spectrometry, crystal structure of the CPSF160-WDR33 subcomplex and biochemical assays, we define the molecular architecture of the core human CPSF complex, identifying specific domains involved in inter-subunit interactions. In addition to zinc finger domains in CPSF30, we identify using quantitative RNA binding assays an N-terminal lysine/arginine-rich motif in WDR33 as a critical determinant of specific AAUAAA motif recognition. Together, these results shed light on the function of CPSF in mediating PAS-dependent RNA cleavage and polyadenylation.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Human</kwd></kwd-group><funding-group><award-group id="par-1"><funding-source><institution-wrap><institution>European Research Council</institution></institution-wrap></funding-source><award-id>ERC-StG-337284</award-id><principal-award-recipient><name><surname>Clerici</surname><given-names>Marcello</given-names></name><name><surname>Jinek</surname><given-names>Martin</given-names></name></principal-award-recipient></award-group><award-group id="par-2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100004410</institution-id><institution>European Molecular Biology Organization</institution></institution-wrap></funding-source><award-id>ALTF-343-2013</award-id><principal-award-recipient><name><surname>Faini</surname><given-names>Marco</given-names></name></principal-award-recipient></award-group><award-group id="par-3"><funding-source><institution-wrap><institution>European Research Council</institution></institution-wrap></funding-source><award-id>HEALTH-F4-2008-201648</award-id><principal-award-recipient><name><surname>Aebersold</surname><given-names>Ruedi</given-names></name></principal-award-recipient></award-group><award-group id="par-4"><funding-source><institution-wrap><institution>European Research Council</institution></institution-wrap></funding-source><award-id>233226</award-id><principal-award-recipient><name><surname>Aebersold</surname><given-names>Ruedi</given-names></name></principal-award-recipient></award-group><award-group id="par-5"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100010663</institution-id><institution>H2020 European Research Council</institution></institution-wrap></funding-source><award-id>670821</award-id><principal-award-recipient><name><surname>Aebersold</surname><given-names>Ruedi</given-names></name></principal-award-recipient></award-group><award-group id="par-6"><funding-source><institution-wrap><institution>Innovative Medicines Initiative Joint Undertaking</institution></institution-wrap></funding-source><award-id>ULTRA-DD grant no. 115766</award-id><principal-award-recipient><name><surname>Aebersold</surname><given-names>Ruedi</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group></article-meta></front><back><sec id="s1" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf1"><p>The authors declare that no competing interests exist.</p></fn></fn-group></sec><sec id="s2" sec-type="supplementary-material"><title>Additional Files</title><sec id="s3" sec-type="datasets"><title>Major datasets</title><p/><p>The following datasets were generated:</p><p><related-object content-type="generated-dataset" id="dataro1" source-id="https://www.rcsb.org/pdb" source-id-type="uri"><collab>Clerici M</collab>, <collab>Jinek M</collab>, <year>2017</year><x>,</x> <source>Crystal structure of the human CPSF160-WDR33 complex</source><x>,</x> <ext-link ext-link-type="uri" xlink:href="https://www.rcsb.org/pdb">https://www.rcsb.org/pdb</ext-link><x>,</x> <comment>6F9N</comment></related-object><related-object content-type="generated-dataset" id="dataro2" source-id="http://www.proteomexchange.org/" source-id-type="uri"><collab>Faini M</collab>, <collab>Aebersold R.</collab>, <year>2017</year><x>,</x> <source>CPSF160-WDR33-CPSF30-Fip1 MS raw data and cross-linking results</source><x>,</x> <ext-link ext-link-type="uri" xlink:href="http://www.proteomexchange.org/">http://www.proteomexchange.org/</ext-link><x>,</x> <comment>PXD008122</comment></related-object></p></sec><supplementary-material><ext-link xlink:href="elife-33111-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material></sec></back></article>